Advertisement

PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 2–2 | Cite as

FDA guidance on interchangeable biological products

News item
  • 3 Downloads

Reference

  1. Statement from Acting FDA Commissioner Ned Sharpless, M.D., on policy advancements to help bring interchangeable biosimilars to market. Internet Document : 15 May 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-acting-fda-commissioner-ned-sharpless-md-policy-advancements-help-bring-interchangeable

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations